Protein block stops vascular damage in diabetes

Researchers at Lund University in Sweden have discovered how to stop the destructive process that leads to cardiovascular disease in diabetic laboratory animals.

It is well known that levels significantly raise the risk of cardiovascular disease. It is unclear, however, why this happens. An important part of the explanation may be NFAT, a protein activated when blood sugar is raised and which starts a chain of events that damage the blood vessels and accelerate the development of atherosclerosis.

"We have now shown that it is possible to stop the atherosclerosis caused by diabetes despite the fact that the mice continued to have high ", said Maria Gomez, a researcher at the Lund University Diabetes Centre. Over the course of four weeks, the researchers gave diabetic mice a new substance originally developed as an immunosuppressant that prevented the activation of the NFAT protein.

Apart from the blood vessels, the substance did not affect NFAT in any other cells of the body.

"That is important. We don't want to suppress the whole immune system. We also saw that the substance only has an effect when NFAT is active. The was only stopped in diabetic mice and not in non-diabetic mice, which had levels", Anna Zetterqvist points out.

"It appears that there are different mechanisms behind plaque formation caused by diabetes and not caused by diabetes", she added.

The process of plaque formation in the blood vessels of resembles the process in humans. The plaques go through the same stages and the damage worsens with age.

"Despite major progress in the treatment of cardiovascular disease in recent decades, there is no treatment that specifically targets the damage to the blood vessels experienced by . Our findings show that blocking the NFAT protein could constitute such a treatment", said Maria Gomez.

More information: 'Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic mice', PLOS ONE, June 3, 2013.

add to favorites email to friend print save as pdf

Related Stories

The search for an early biomarker to fight atherosclerosis

May 14, 2013

The Journal of the American Heart Association published the conclusive results from a study directed by Dr. Éric Thorin of the Montreal Heart Institute (MHI), which suggests for the first time that a blood protein contri ...

Diabetes drug may reduce brain damage after stroke

Dec 03, 2012

In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for ...

Recommended for you

Scientist finds clearer obesity, diabetes connection

Aug 27, 2014

(Medical Xpress)—New findings about the biological links between obesity and insulin resistance and Type 2 diabetes may also shed light on the connection between obesity and cancer, says a scientist at ...

User comments